Dr. Thompson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Elm And Carlton St
Buffalo, NY 14263Phone+1 716-845-7110- Is this information wrong?
Education & Training
Northwestern UniversityMS, Medical Informatics, 2013 - 2018
University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2000 - 2003- University of Pennsylvania Health SystemResidency, Internal Medicine, 1997 - 2001
Columbia University Vagelos College of Physicians and SurgeonsClass of 1997
Certifications & Licensure
NY State Medical License 2008 - 2024
PA State Medical License 1998 - 2010- American Board of Internal Medicine Hematology
- American Board of Preventive Medicine Clinical Informatics
Clinical Trials
- Evaluation of KX2-391 in Elderly Subjects With Acute Myeloid Leukemia (AML) Start of enrollment: 2013 Dec 01
Publications & Presentations
PubMed
- 1 citationsPivekimab sunirine (IMGN632), a novel CD123-targeting antibody-drug conjugate, in relapsed or refractory acute myeloid leukaemia: a phase 1/2 study.Naval G Daver, Pau Montesinos, Daniel J DeAngelo, Eunice S Wang, Nikolaos Papadantonakis, Elisabetta Todisco, Kendra L Sweet, Naveen Pemmaraju, Andrew A Lane, Laura To...> ;The Lancet. Oncology. 2024 Mar 1
- Chronic Myeloid Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.Neil P Shah, Ravi Bhatia, Jessica K Altman, Maria Amaya, Kebede H Begna, Ellin Berman, Onyee Chan, Joan Clements, Robert H Collins, Peter T Curtin, Daniel J DeAngelo, ...> ;Journal of the National Comprehensive Cancer Network. 2024 Feb 1
- Estimated Savings After Stopping Tyrosine Kinase Inhibitor Treatment Among Patients With Chronic Myeloid Leukemia.Winn, A., Deininger, M., Moore, J., Shah, N., Flynn, K., Atallah, E., Cortes, J., Kota, V., Larson, R., Mauro, M., Oehler, V., Pinilla-Ibarz, J., Radich, J., Thompson, J.> ;JAMA Network Open. 2023 Dec 1
- Join now to see all
Abstracts/Posters
- Outcomes of Venetoclax-Based Regimens Compared with Hypomethylating Agents (HMA) Alone or 7+3 in Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia (AML): A ...James E. Thompson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Quantification of Humoral Immune Response to Influenza Vaccination in MDSJames E. Thompson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Benefits of a Pharmacist Led Oral Chemotherapy Monitoring Program for Patients with Chronic Myeloid Malignancies: A Patient Reported Outcome (PRO) StudyJames E. Thompson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Press Mentions
Roswell Park Licenses Rapid, Comprehensive Blood Test to Agilent, a Global Leader in the Life Sciences MarketOctober 20th, 2023
Professional Memberships
- Member
- Member
Hospital Affiliations
Roswell Park Comprehensive Cancer CenterBuffalo, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
